# Avalo Therapeutics (AVTX) Stock Price, News & Catalysts
Canonical URL: https://biopharmsignal.com/company/AVTX
## Company Profile
- Ticker: AVTX
- Exchange: NASDAQ
- Sector: Biopharma
- Location: United States
- Tags: Immunology
## Stock Data
- Close: 19.55 USD
- Market cap: 733815385.12 USD
- Last updated: 2026-08-12
## Business Overview
### Clinical Immunology Company
Avalo Therapeutics develops therapies for immune-mediated inflammatory diseases.
### Abdakibart
Abdakibart is an antibody targeting IL-1β and is being developed for moderate-to-severe hidradenitis suppurativa.
### LOTUS Evidence
The Phase 2 LOTUS study met its primary endpoint at both evaluated doses, supporting advancement into registrational development.
## Why The Stock Is Moving

As of Aug 12, 2026, AVTX closed up 0.41% at $19.55. No new same-company headline was identified in the current news window.

## Future Catalysts

- Avalo plans to advance abdakibart into a Phase 3 registrational program in hidradenitis suppurativa.

## Drug Assets

- AVTX-009

## Recent News
- 2026-08-06 11:00 EST — [Avalo Therapeutics Reports Second Quarter 2026 Financial Results and Recent Business Updates](https://biopharmsignal.com/news/AVTX/avalo-therapeutics-reports-second-quarter-2026-financial-results-and-recent-busi-284a6cbe) — Source: Avalo Therapeutics
- 2026-07-22 11:00 EST — [Avalo Therapeutics to Participate in the BTIG Biotechnology Conference](https://biopharmsignal.com/news/AVTX/avalo-therapeutics-to-participate-in-the-btig-biotechnology-conference-399b4284) — Source: Avalo Therapeutics
- 2026-07-07 11:00 EST — [Avalo Therapeutics to Participate in the Leerink Partners Therapeutics Forum](https://biopharmsignal.com/news/AVTX/avalo-therapeutics-to-participate-in-the-leerink-partners-therapeutics-forum-ef62dbcf) — Source: Avalo Therapeutics
- 2026-06-26 11:00 EST — [Avalo Therapeutics to Join the Russell 2000® and Russell 3000® Indexes](https://biopharmsignal.com/news/AVTX/avalo-therapeutics-to-join-the-russell-2000-and-russell-3000-indexes-3ee6d18b) — Source: Avalo Therapeutics
- 2026-06-23 11:00 EST — [Avalo Therapeutics Appoints Ron Philip to Board of Directors](https://biopharmsignal.com/news/AVTX/avalo-therapeutics-appoints-ron-philip-to-board-of-directors-7373732c) — Source: Avalo Therapeutics